Orange Book product · Generic (ANDA)
GLIPIZIDE
GLIPIZIDE
At a glance
May 12, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 12, 2017
9 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
GLIPIZIDE
Strength
2.5MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 206928
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GLIPIZIDE
- 1999GLUCOTROL XLBrand (NDA)
NDA 020329 · PFIZER
- 1993GLUCOTROLBrand (NDA)
NDA 017783 · PFIZER
- 2026GLIPIZIDEGeneric (ANDA)
ANDA 219159 · GRAVITI PHARMS
- 2023GLIPIZIDEGeneric (ANDA)
ANDA 214874 · RUBICON RESEARCH
- 2018GLIPIZIDEGeneric (ANDA)
ANDA 203499 · ZYDUS PHARMS
- 2016GLIPIZIDEGeneric (ANDA)
ANDA 204720 · UNIQUE
- 2015GLIPIZIDEGeneric (ANDA)
ANDA 202298 · PHARMOBEDIENT
- 2013GLIPIZIDEGeneric (ANDA)
ANDA 076159 · PH HEALTH
- 2006GLIPIZIDEGeneric (ANDA)
ANDA 077820 · SUN PHARM INDS INC
- 2006GLIPIZIDEGeneric (ANDA)
ANDA 076467 · WATSON LABS
- 2001GLIPIZIDEGeneric (ANDA)
ANDA 075795 · APOTEX
- 1997GLIPIZIDEGeneric (ANDA)
ANDA 074550 · ACCORD HLTHCARE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
